Image via WikipediaTop Antibiotic Makers:
Trius Therapeutics--(TSRX)
Forest Labs--(FRX)
Optimer Pharmaceuticals--(OPTR)
These stocks haven't necessarily done extremely well this year, but the high cost of Clinical Trials leads to debt. Once the clinical trials are approved and these antibiotics go on the market these should have noticeable gains. I think these could have potential to invest in the long term futures.
Another company of note is SIGA Technologies (SIGA). SIGA makes bioweapons vaccines for the government and recently announced a government contract for small pox treatment. From Marketwatch: SIGA soars on government contract.
Hope In The Grim Fight Against Drug-Resistant Germs
